Iboga is a natural plant medicine that can halt addiction in its tracks and save lives. Iboga is reported to eliminate cravings and restore a sense of wholeness and purpose with just one treatment. Why …
Summary: MAPS Founder Rick Doblin, Ph.D., speaks to Sounds True about the progress of MDMA-assisted psychotherapy for PTSD in clinical research contexts, and shares personal experiences that led to his …
MAPS Bulletin Winter 2017 Vol. 27, No. 3 – Annual Report Fiscal Year 2016–17 (June 1, 2016–May 31, 2017) Download this article. Download MAPS IRS Form 990 (2016) It’s my pleasure and my responsibility …
Summary: Greg Gutfeld of Fox News interviews Reason senior editor Jacob Sullum to discuss and how MDMA and ibogaine therapy may be potential treatments for the current PTSD and opioid epidemics. Originally …
MAPS staff members provide public comments to governmental bodies about proposed legislation or regulations concerning psychedelics during time periods prescribed by law. Testimony to U.S. Sentencing Commission …
Originally appearing here. Ketamine is quickly gaining popularity for it’s therapeutic value for it’s use in treatment-resistant depression and PTSD therapy. This clinical interest has been …
What is PTSD? PTSD is a chronic, debilitating anxiety disorder that follows a traumatic event. People with PTSD continue to have intense, disturbing thoughts and feelings related to their experience that …
September 8 – 10, 2017 From the event website: The European Ibogaine Forum will take place in Vienna from September 8-10. The conference will bring together some of the leading researchers in the …
Originally appearing here.“The opiates were stealing my life bit by bit,” she confided. For years, she had been eating very little and her nutrition was abysmal, and in more recent years the opiates …
Featured Research Mithoefer M, Grob C, Brewerton T (2016): Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. The Lancet Psychiatry 3 (5): 481–488 Heifets B, Malenk …
The promising results of two MAPS-sponsored observational studies into treating opioid dependence with ibogaine, a naturally occurring psychedelic compound, have been published in the peer-reviewed American …
MAPS Bulletin Winter 2016 Vol. 26, No. 3 – Annual Report Fiscal Year 2015–16 (June 1, 2015–May 31, 2016) Download this article. Download MAPS IRS Form 990 (2016) Download Audited Financial Statements …